NGC Update Service: April 13, 2015 ► U.S. Food and Drug Administration (FDA) Advisory

NGC Update Service: April 13, 2015

U.S. Food and Drug Administration (FDA) Advisory

• March 31, 2015: Feraheme (ferumoxytol): FDA is strengthening an existing warning that serious, potentially fatal allergic reactions can occur with the anemia drug Feraheme (ferumoxytol). FDA changed the prescribing instructions and approved a Boxed Warning regarding these serious risks. Also added is a new Contraindication, a strong recommendation against use of Feraheme in patients who have had an allergic reaction to any intravenous (IV) iron replacement product.